NASDAQ:LSAQ

LifeSci Acquisition II Stock Forecast, Price & News

$10.10

-0.33 (-3.16 %)

(As of 10/22/2021 12:00 AM ET)

Add

Compare

Today's Range

$10.06

▼

$11.09

50-Day Range

$9.01

▼

$12.31

52-Week Range

$8.42

▼

$12.68

Volume149,791 shs

Average Volume53,514 shs

Market Capitalization$101.11 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive LSAQ News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeSci Acquisition II and its competitors with MarketBeat's FREE daily newsletter.

About LifeSci Acquisition II

LifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2019 and is based in New York, New York.

With SPAC deal done, Triangle science company hits public markets
October 7, 2021 | finance.yahoo.com

Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE
October 7, 2021 | finance.yahoo.com

October SPAC Merger Calendar: A Look At Upcoming Votes, Stocks To Watch
October 4, 2021 | markets.businessinsider.com

LifeSci Acquisition II Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination
June 16, 2021 | finance.yahoo.com

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of LifeSci Acquisition II Corp. - LSAQ
May 12, 2021 | finance.yahoo.com

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of LifeSci Acquisition II Corp. Merger
May 12, 2021 | finance.yahoo.com

Science 37 Taps SPAC For NASDAQ Listing Valued At Around $1B
May 7, 2021 | finance.yahoo.com

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of LifeSci Acquisition II Corp. (Nasdaq – LSAQ)
May 7, 2021 | finance.yahoo.com

Science 37 Is Going Public Via LifeSci II SPAC Merger
May 7, 2021 | bloomberg.com

Instant Unicorn: Triangle science company goes public through SPAC merger
May 7, 2021 | bizjournals.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:LSAQ
Previous Symbol
CUSIP: N/A
CIK: 1819113
Web: lifesciacquisition.com
Phone: 646-899-1200
Employees: 2
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.50 per share
Price / Book: 20.20

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.07
Quick Ratio: 4.07

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 10,011,000
Market Cap: $101.11 million
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.33 out of 5 stars

Medical Sector

1314th out of 1,359 stocks

Commercial Physical Research Industry

23rd out of 26 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for LifeSci Acquisition II.

0.0 Community Rank

Outperform Votes
LifeSci Acquisition II has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
LifeSci Acquisition II has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about LifeSci Acquisition II and other stocks. Vote “Outperform” if you believe LSAQ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LSAQ will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
LifeSci Acquisition II does not currently pay a dividend.
Dividend Growth
LifeSci Acquisition II does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LifeSci Acquisition II insiders have not sold or bought any company stock.
Percentage Held by Institutions
71.68% of the stock of LifeSci Acquisition II is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0 Earnings and Valuation

Price to Book Value per Share Ratio
LifeSci Acquisition II has a P/B Ratio of 20.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

LifeSci Acquisition II (NASDAQ:LSAQ) Frequently Asked Questions

What stocks does MarketBeat like better than LifeSci Acquisition II?: Wall Street analysts have given LifeSci Acquisition II a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but LifeSci Acquisition II wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are LifeSci Acquisition II's key executives?: LifeSci Acquisition II's management team includes the following people:
Dr. Andrew Ian McDonald Ph.D., Chairman & CEO (Age 47)
Mr. David Dobkin, CFO, Head of Strategy & Director (Age 42)
Mr. Michael Yehuda Rice, COO & Director (Age 56)
Who are some of LifeSci Acquisition II's key competitors?: Some companies that are related to LifeSci Acquisition II include SomaLogic (SLGC), Starpharma (SPHRY), CM Life Sciences II (CMII), Luna Innovations (LUNA), Auxly Cannabis Group (CBWTF), Eloxx Pharmaceuticals (ELOX), Bioqual (BIOQ), AIkido Pharma (AIKI), AIkido Pharma (AIKI), Inhibitor Therapeutics (INTI), HedgePath Pharmaceuticals (HPPI), iSpecimen (ISPC), ProMIS Neurosciences (ARFXF), Vitality Biopharma (VBIO) and U.S. Stem Cell (USRM).
View all of LSAQ's competitors.
When did LifeSci Acquisition II IPO?: (LSAQ) raised $75 million in an initial public offering (IPO) on Friday, November 20th 2020. The company issued 7,500,000 shares at a price of $10.00 per share. LifeSci Capital and Ladenburg Thalmann served as the underwriters for the IPO.
What is LifeSci Acquisition II's stock symbol?: LifeSci Acquisition II trades on the NASDAQ under the ticker symbol "LSAQ."
How do I buy shares of LifeSci Acquisition II?: Shares of LSAQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is LifeSci Acquisition II's stock price today?: One share of LSAQ stock can currently be purchased for approximately $10.10.
How much money does LifeSci Acquisition II make?: LifeSci Acquisition II has a market capitalization of $101.11 million.
How many employees does LifeSci Acquisition II have?: LifeSci Acquisition II employs 2 workers across the globe.
What is LifeSci Acquisition II's official website?: The official website for LifeSci Acquisition II is lifesciacquisition.com.
How can I contact LifeSci Acquisition II?: The company can be reached via phone at 646-899-1200 or via email at [email protected].

This page was last updated on 10/24/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

LifeSci Acquisition II Stock Forecast, Price & News

About LifeSci Acquisition II

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes

0.0 Dividend Strength

Dividend Yield

Dividend Growth

1.7 Company Ownership

Insider Buying vs. Insider Selling

Percentage Held by Institutions

0.0 Earnings and Valuation

Price to Book Value per Share Ratio

LifeSci Acquisition II (NASDAQ:LSAQ) Frequently Asked Questions

What stocks does MarketBeat like better than LifeSci Acquisition II?

Who are LifeSci Acquisition II's key executives?

Who are some of LifeSci Acquisition II's key competitors?

When did LifeSci Acquisition II IPO?

What is LifeSci Acquisition II's stock symbol?

How do I buy shares of LifeSci Acquisition II?

What is LifeSci Acquisition II's stock price today?

How much money does LifeSci Acquisition II make?

How many employees does LifeSci Acquisition II have?

What is LifeSci Acquisition II's official website?

How can I contact LifeSci Acquisition II?